Procurement of medicines for 2026 Biological therapy
- Published
- 28 April 2026
- Place of performance
- MKZZZ
- Notice number
- 00291157-2026
- Reference
- 91b36808-6f46-4e88-a6ab-30dd6cdf0d61
- Official source
- Official source
CPV codes
- 33600000Pharmaceutical products
Description
Procurement of medicines for 2026 Biological therapy
Lots (41)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | 1 L01ED03 Alectinib 150 mg | 33600000 Pharmaceutical products | — |
| 2 | 2 L01FF05 Atezolizumab 1875 mg/15 ml | 33600000 Pharmaceutical products | — |
| 3 | 3 L01EK01 Axitinib | 33600000 Pharmaceutical products | — |
| 4 | 4 L01FG01 Bevacizumab originator | 33600000 Pharmaceutical products | — |
| 5 | 5 L01FG01 Bevacizumab biosimilar | 33600000 Pharmaceutical products | — |
| 6 | 6 L01EE02 Cobimetinib | 33600000 Pharmaceutical products | — |
| 7 | 7 Cetuximab solution for infusion 5 mg/mlx20 ml | 33600000 Pharmaceutical products | — |
| 8 | 8 L01XE03 Erlotinib | 33600000 Pharmaceutical products | — |
| 9 | 9 L02BA03 Fulvestrant 250 mg | 33600000 Pharmaceutical products | — |
| 10 | 10 L01XA03 Oxaliplatin 50 mg | 33600000 Pharmaceutical products | — |
| 11 | 11 L01XA03 Oxaliplatin 100 mg | 33600000 Pharmaceutical products | — |
| 12 | 12 L01FF02 Pembrolizumab | 33600000 Pharmaceutical products | — |
| 13 | 13 L01EX03 Pazopanib | 33600000 Pharmaceutical products | — |
| 14 | 14 L01XE33 Palbociclib 125 mg | 33600000 Pharmaceutical products | — |
| 15 | 15 L01XE33 Palbociclib 100 mg | 33600000 Pharmaceutical products | — |
| 16 | 16 L01XE33 Palbociclib 75 mg | 33600000 Pharmaceutical products | — |
| 17 | 17 L01BA04 Pemetrexed 25mg/ml | 33600000 Pharmaceutical products | — |
| 18 | 18 L01EF02 Ribociclib 200 mg | 33600000 Pharmaceutical products | — |
| 19 | 19 L01EX01 Sunitinib 50mg | 33600000 Pharmaceutical products | — |
| 20 | 20 L01XE05/L01EX02 Sorafenib 200 mg | 33600000 Pharmaceutical products | — |
| 21 | 21 L01FD03 Trastuzumab emtansine 100 mg/15 ml | 33600000 Pharmaceutical products | — |
| 22 | 22 L01XC014 Trastuzumab emtansine 160 mg/20 ml | 33600000 Pharmaceutical products | — |
| 23 | 23 L01XY02 Pertuzumab/ trastuzumab 1200 mg/600 mg | 33600000 Pharmaceutical products | — |
| 24 | 24 L01XY02 Pertuzumab/ trastuzumab 600 mg/600 mg | 33600000 Pharmaceutical products | — |
| 25 | 25 L02BX03 Abiraterone 250 mg | 33600000 Pharmaceutical products | — |
| 26 | 26 L02BX03 Abiraterone 500 mg | 33600000 Pharmaceutical products | — |
| 27 | 27 L01XE15 Vemurafenib 240 mg | 33600000 Pharmaceutical products | — |
| 28 | 28 L01XE35 Osimertinib 80 mg | 33600000 Pharmaceutical products | — |
| 29 | 29 L01ED05 Lorlatinib 100 mg | 33600000 Pharmaceutical products | — |
| 30 | 30 L01FF01 Nivolumab 40 mg | 33600000 Pharmaceutical products | — |
Official publications
- TED · 00291157-2026 · 28 April 2026
- OJS · 82/2026 · 28 April 2026
Other tenders from University clinic of radiotherapy and oncology
- Procurement of medical supplies
- Full service (regular maintenance and interventional servicing) for therapy machines
- Laboratory reagents and materials
- Procurement of medicines for 2026 Biological therapy
- Drugs that are registered and on the positive list
- Equipment for Brachy therapy
- Laboratory reagents and materials
- Laboratory reagents and materials
- Medicines
- Halcyon MV System Linear Accelerator Service
Frequently asked questions
- Who is the buyer of this tender?
- The contracting authority is University clinic of radiotherapy and oncology (European Union).
- How can I bid for public tenders in the European Union?
- Bids are submitted through the official public procurement portal in the European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the European Union that match your business, every day.
Create a free account and receive new public tenders published in the European Union that match your business, every day.